Prosecution Insights
Last updated: August 16, 2026
Application No. 17/967,249

TWO-PART THERMAL CONDUCTIVE EPOXY ADHESIVE COMPOSITION

Non-Final OA §103§112
Filed
Oct 17, 2022
Priority
Apr 15, 2020 — continuation of PCTCN2020084899
Examiner
CAI, WENWEN
Art Unit
1763
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Henkel AG & Co. KGaA
OA Round
2 (Non-Final)
60%
Grant Probability
Moderate
2-3
OA Rounds
0m
Est. Remaining
80%
With Interview

Examiner Intelligence

Grants 60% of resolved cases
60%
Career Allowance Rate
519 granted / 871 resolved
-5.4% vs TC avg
Strong +20% interview lift
Without
With
+19.9%
Interview Lift
resolved cases with interview
Typical timeline
3y 2m
Avg Prosecution
64 currently pending
Career history
938
Total Applications
across all art units

Statute-Specific Performance

§101
1.1%
-38.9% vs TC avg
§103
45.0%
+5.0% vs TC avg
§102
17.2%
-22.8% vs TC avg
§112
28.7%
-11.3% vs TC avg
Black line = Tech Center average estimate • Based on career data from 871 resolved cases

Office Action

§103 §112
DETAILED ACTION The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Response to Amendment The amendment of claims 11, 14, 16-18 are supported by the specification. Any rejections and/or objections made in the previous Office action and not repeated below are hereby withdrawn. The text of those sections of Title 35, U.S. Code not included in this action can be found in a prior Office action. The new grounds of rejection set forth below are necessitated by applicant's amendment filed on 5/26/2026. Thus, the following action is properly made final. Claim Objections Claims 2-4, 8, 10-12, 14-18 objected to because of the following informalities: the preamble should be consistent with the independent claim. Appropriate correction is required. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(a): (a) IN GENERAL.—The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor or joint inventor of carrying out the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), first paragraph: The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same and shall set forth the best mode contemplated by the inventor of carrying out his invention. Claims 1-4, 8, 10-12, 14-18, 20 rejected under 35 U.S.C. 112(a) or 35 U.S.C. 112 (pre-AIA ), first paragraph, as failing to comply with the written description requirement. The claim(s) contains subject matter which was not described in the specification in such a way as to reasonably convey to one skilled in the relevant art that the inventor or a joint inventor, or for pre-AIA the inventor(s), at the time the application was filed, had possession of the claimed invention. Claim 1 recites “the two parts of the composition when mixed exhibit modulus at room temperature of 2000 MPa or less”, the specification disclose a cured two part epoxy adhesive having modulus of no more than 2000 MPa with the thermal conductive filler loading of more than 60%. Claims 1-4, 8, 10-12, 14-18, 20 rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor, or for pre-AIA the applicant regards as the invention. Claim 8 is dependent on a cancelled claim. For purposes of expediting prosecution, claim 8 is interpreted as dependent from claim 1. Claim Rejections - 35 USC § 103 Claims 1-4, 8, 10-12, 14-18, 20 is/are rejected under 35 U.S.C. 103 as being unpatentable over Elgimiabi (US 2011/0244245). Claims 1-4, 8, 10-11, 15-17: Elgimiabi teaches a composition comprising bisphenol A based diglycidyl ether EPON 828, core shell rubber toughened epoxy resin based on bisphenol A Kane MX 153, epoxy diluent 1,4-cyclohexane dimethanol diglycidyl ether EPODIL 757, and a polyamido amine curing agent ANCAMIDE 910 which reads on formula I and identical to the compound used in instant application, and aluminum hydroxide, and aother amine curing agent TTD 4,7,10-trioxamidecane-1,13-diamine, and silica (tables 1-2). The equivalent ratio of amine from ANCAMIDE 910 to the epoxy is 0.7. Elgimiabi further teaches the amine curing agent can be one or more amine curing agents, and in the composition the ratio of amine equivalent to epoxy equivalent is about 1:1 [0065, 0103]. Therefore, it would have been obvious to one of ordinary skill in the art at the time the invention was made to recognize the amine equivalent from ANCAMIDE 910 overlaps the claimed range when only one amine curing agent ANCAMIDE 910 is used. Elgimiabi is silent with respect to the property of the composition. However, the teachings from Elgimiabi have rendered obvious the instantly claimed ingredients and amounts thereof. Therefore, it is reasonable that one of ordinary skill in the art would expect the claimed physical properties to naturally arise. Claim 12: The composition comprises a phosphoric acid ester as a bonding promoter [0007, table 2], which reads on a coupling agent. Claim 14: the composition comprises a thixotropic agent silica with amine curing agent [table 1]. It is noted that instant claims recites a composition comprising in two parts. For the final mixed composition, the silica in part A or part B is a matter of different order of processing which does not affect or change the characteristic of the final composition. Case law holds that selection of any order of performing process steps or mixing ingredients is prima facie obvious in the absence of new or unexpected results; In re Gibson, 39 F.2d 975, 5 USPQ 230 (CCPA 1930), In re Burhans, 154 F.2d 690, 69 USPQ 330 (CCPA 1946). Therefore, it would have been obvious to one of ordinary skill in the art at the time the invention was made to recognize that the silica can also be in the epoxy part. Claim 18: Elgimiabi discloses aluminum hydroxide can be included in both parts A and B at a concentration of 26 and 28 wt% respectively. Elgimiabi does not require aluminum hydroxide has to be in both parts. Elgimiabi does not teach the content of aluminum hydroxide is 35-80 wt% in parts A or B. However, it would have been obvious to one of ordinary skill in the art at the time the invention was made to recognize that aluminum hydroxide can be included in only one part having a concentration overlapping the claimed range to achieve the desired final content in the adhesive composition because this is a matter of different order of processing. Claim 20: Elgimiabi teaches an assembly comprising the adhesive and a substrate [0105-0110, 0116-0117]. It is noted that claim 20 is a product-by-process claim. Case law holds that “even though product-by-process claims are limited by and defined by the process, determination of patentability is based on the product itself. The patentability of a product does not depend on its method of production. If the product in the product-by-process claim is the same as or obvious from a product of the prior art, the claim is unpatentable even though the prior product was made by a different process.” See In re Thorpe, 777 F.2d 695, 698, 227 USPQ 964, 966 (Fed. Cir. 1985). Response to Arguments Applicant's arguments filed 5/26/2026 have been fully considered but they are not persuasive. In response to applicant's argument regarding unexpected results, the data have been fully considered, however, they are insufficient to establish unexpected results given that 1) the data is related to a mixture after mixing part A and part B while the claim is directed to a composition comprising in two parts; 2) the data is not compared to the closest prior art, 3) the data is not reasonably commensurate in scope with the scope of claims. The inventive data only contains a specific species of each component as compared to the claimed genus, and the inventive data only contain a specific amount of each component as compared to the claimed general recitation. Case law holds that evidence is insufficient to rebut a prima facie case if not commensurate in scope with the claimed invention. In re Grasselli, 713 F.2d 731, 741, 218 USPQ 769, 777 (Fed. Cir. 1983). 4) Ex3-Ex8 and CEx 5 show a clear trend of tensile modulus/lap shear strength decreases with the increase of formula I amine equivalent to the epoxy equivalent. The higher ratio means more unreacted amine and therefore lower crosslinking density, which eventually leading to a poorer adhesion is a known fact. Case law holds that "discovery of an optimum value of a result effective variable in a known process is ordinarily within the skill of the art." In re Antonie, 559 F.2d 618, 195 USPQ 6 (CCPA 1977). In re Boesch, 617 F.2d 272, 205 USPQ 215 (CCPA 1980). Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any extension fee pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to WENWEN CAI whose telephone number is (571)270-3590. The examiner can normally be reached on M-F 9am-6pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Joseph Del Sole can be reached on (571)272-1130. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /WENWEN CAI/ Primary Examiner, Art Unit 1763
Read full office action

Prosecution Timeline

Oct 17, 2022
Application Filed
Jan 26, 2026
Non-Final Rejection mailed — §103, §112
May 26, 2026
Response Filed
Jun 11, 2026
Final Rejection mailed — §103, §112
Aug 07, 2026
Response after Non-Final Action

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12702629
EVAPORATION STRATEGY GENERATED ANTIBACTERIAL ENAMEL-LIKE FLUORAPATITE-POLYACRYLIC ACID SHEET FOR FUNCTIONAL DENTAL RESTORATION
3y 9m to grant Granted Aug 11, 2026
Patent 12692328
B-STAGEABLE AQUEOUS BINDER COMPOSITIONS
4y 10m to grant Granted Jul 28, 2026
Patent 12655247
TWO COMPONENT COATING COMPOSITIONS
4y 9m to grant Granted Jun 16, 2026
Patent 12630685
MXENE ENHANCED URETHANE FOAM
3y 6m to grant Granted May 19, 2026
Patent 12617941
HEAT-CURABLE RESIN COMPOSITION
2y 12m to grant Granted May 05, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

2-3
Expected OA Rounds
60%
Grant Probability
80%
With Interview (+19.9%)
3y 2m (~0m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 871 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month